01 1Divis Laboratories
01 1NABUMETONE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-30
Pay. Date : 2015-12-23
DMF Number : 15364
Submission : 2001-04-02
Status : Active
Type : II
20
Divis Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NABUMETONE USP, with a corresponding US DMF Number 15364.
Remarkably, this DMF maintains an Active status since its submission on April 02, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 30, 2016, and payment made on December 23, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
